Key facts
- A significant player in the royalty financing sector has established a presence in Hong Kong.
- There has been a notable increase in deal-making within China's biotechnology sector.
A prominent entity in the royalty financing sector has launched a new base in Hong Kong. This strategic expansion occurs against a backdrop of escalating deal activity within mainland China's biotechnology industry, indicating a growing trend of investment and collaboration in the region's life sciences market.